Results 31 to 40 of about 4,808,959 (304)

Molecular genomic features associated with in vitro response of the NCI‐60 cancer cell line panel to natural products

open access: yesMolecular Oncology, 2021
Natural products remain a significant source of anticancer chemotherapeutics. The search for targeted drugs for cancer treatment includes consideration of natural products, which may provide new opportunities for antitumor cytotoxicity as single agents ...
Julia Krushkal   +10 more
doaj   +1 more source

Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma

open access: yesMolecular Oncology, 2023
The identification of the high‐efficiency and non‐invasive biomarkers for hepatocellular carcinoma (HCC) detection is urgently needed. This study aims to screen out potential autoantibodies to tumor‐associated antigens (TAAbs) and to assess their ...
Qian Yang   +9 more
doaj   +1 more source

ON THE TREATMENT OF CANCER. [PDF]

open access: yesThe Lancet, 1887
n ...
openaire   +1 more source

Blastomycosis Presenting as Multiple Splenic Masses

open access: yesCanadian Journal of Infectious Diseases, 1995
Blastomyces dermatitidis is a fungus that causes a wide spectrum of disease in humans. The clinical and pathological entity of splenic abscess due to blastomycosis is extremely rare.
Tahir Ijaz   +5 more
doaj   +1 more source

The Jekyll and Hyde story of IL17 producing γδT (Tγδ17) cells

open access: yesFrontiers in Immunology, 2015
In comparison to conventional αβT cells, γδT cells are considered as specialized T cells based on their contributions in regulating immune response. γδT cells sense early environmental signals and initiate local immunosurveillance.
Rushikesh Sudam Patil   +3 more
doaj   +1 more source

Comprehensive Landscape of HOXA2, HOXA9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in Prostate Cancer

open access: yesJournal of Immunology Research, 2022
Prostate cancer (PCa) is recognized as a common malignancy in male patients. The homeobox A cluster (HOXA) family members have been confirmed to be implicated in the development of several types of tumors.
Yan-ping Song   +6 more
doaj   +1 more source

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma. [PDF]

open access: yes, 2016
Prostate cancer is the most commonly diagnosed malignancy and second leading cause of cancer death among men in the United States. In recent years, several new agents, including cancer immunotherapies, have been approved or are currently being ...
Bander, Neil H   +17 more
core   +1 more source

Fluctuations and noise in cancer development

open access: yes, 2004
This paper explores fluctuations and noise in various facets of cancer development. The three areas of particular focus are the stochastic progression of cells to cancer, fluctuations of the tumor size during treatment, and noise in cancer cell ...
Abbott, Derek   +3 more
core   +1 more source

Tyrol Prostate Cancer Demonstration Project : early detection, treatment, outcome, incidence and mortality [PDF]

open access: yes, 2008
This study aimed to evaluate the effectiveness of a well-controlled programme of early detection and treatment of prostate cancer in the population of Tyrol, Austria, where such a programme of early detection and treatment was initiated in 1988 and where
Bartsch, Georg   +13 more
core   +1 more source

Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: A review of the National Cancer Database [PDF]

open access: yes, 2017
For elderly patients with locally advanced esophageal cancer, therapeutic approaches and outcomes in a modern cohort are not well characterized. Patients ≥70 years old with clinical stage II and III esophageal cancer diagnosed between 1998 and 2012 were ...
Bradley, Jeffrey D   +10 more
core   +2 more sources

Home - About - Disclaimer - Privacy